Study of Pentraxin-3 as an Early Marker of Diabetic Vascular Complications in Children and Adolescents with Type 1 Diabetes Mellitus
Mohammed Diya Eldin Mahmoud Fekry;
Abstract
Diabetes is a complex, chronic illness requiring continuous medical care with multifactorial risk-reduction strategies beyond glycemic control.
Complications of T1DM:
(I) Acute complications
1. Diabetic ketoacidosis (DKA).
2. Hypoglycemia.
3. Hyperosmolar non-ketotic coma.
(II) Chronic complications:
{A} Macrovascular complications: CVD is a more common cause of death than microvascular complications in populations with diabetes. There is evidence for a cardiovascular benefit of intensive glycemic control after long-term follow-up of cohorts treated early in the course of type 1 diabetes
{B} Microvascular complications:
A1- Diabetic retinopathy.
A2- Diabetic neuropathy.
A3- Diabetic nephropathy.
Complications of T1DM:
(I) Acute complications
1. Diabetic ketoacidosis (DKA).
2. Hypoglycemia.
3. Hyperosmolar non-ketotic coma.
(II) Chronic complications:
{A} Macrovascular complications: CVD is a more common cause of death than microvascular complications in populations with diabetes. There is evidence for a cardiovascular benefit of intensive glycemic control after long-term follow-up of cohorts treated early in the course of type 1 diabetes
{B} Microvascular complications:
A1- Diabetic retinopathy.
A2- Diabetic neuropathy.
A3- Diabetic nephropathy.
Other data
| Title | Study of Pentraxin-3 as an Early Marker of Diabetic Vascular Complications in Children and Adolescents with Type 1 Diabetes Mellitus | Other Titles | دراسة بروتين بنتراكسين -3 كمؤشر مبكر على مضاعفات الأوعية الدموية لداء السكري في الأطفال والمراهقين الذين يعانون من داء السكري النوع الأول | Authors | Mohammed Diya Eldin Mahmoud Fekry | Issue Date | 2021 |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| BB11810.pdf | 855.1 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.